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Abstract
Nasopharyngeal carcinoma (NPC) is a complex disease caused by a combination of Epstein–Barr virus chronic infection, the environment
and host genes in a multi-step process of carcinogenesis.The identity of genetic factors involved in the development of chronic Epstein–Barr
virus infection and NPC remains elusive, however. Here, we describe a two-phase, population-based, case-control study of Han Chinese
from Guangxi province, where the NPC incidence rate rises to a high of 25–50 per 100,000 individuals. Phase I, powered to detect
single gene associations, enrolled 984 subjects to determine feasibility, to develop infrastructure and logistics and to determine error rates
in sample handling. A microsatellite screen of Phase I study participants, genotyped for 319 alleles from 34 microsatellites spanning an
18-megabase region of chromosome 4 (4p15.1-q12), previously implicated by a linkage analysis of familial NPC, found 14 alleles marginally
associated with developing NPC or chronic immunoglobulin A production ( p ¼ 0.001 2 0.03). These associations lost signiﬁcance after
applying a correction for multiple tests. Although the present results await conﬁrmation, the Phase II study population has tripled patient
enrolment and has included environmental covariates, offering the potential to validate this and other genomic regions that inﬂuence the
onset of NPC.
Keywords: nasopharyngeal carcinoma, chromosome 4, microsatellite, association study, Epstein–Barr virus
Introduction
Nasopharyngeal carcinoma (NPC) is a diseasewith distinct racial
and geographical distributions. In southern China, Taiwan,
Vietnam and the Philippines, the incidence ofNPC is 15–20 per
100,000 individuals per year, and in some local Chinese regions
bordering the Xijiang River drainage in Guangdong and
Guangxi provinces, the incidence is as high as 25–50 per
100,000 individuals.
1,2
An intermediate incidence is observed
among the Arab populations of Northern Africa,
3
including
Saudi Arabia;
4
in the Caribbean; and in the Eskimo populations
of Alaska and Greenland.
5
Elsewhere, NPC is rare, with an
incidence of less than 1 per 100,000. In the USA, NPC com-
prises only 0.2 per cent of all malignancies, with an incidence is
1 per 100,000. The male:female ratio for NPC is usually 2 or
3:1, with an incidence peak between 50 and 59 years of age.
6
A link between NPC and Epstein–Barr virus (EBV)
was reported in 1966.
7
Ten years later, the presence of
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immunoglobulin (Ig) A antibodies to EBV viral capsid antigens
(EBV/IgA/VCA) was found to serve as a predictive marker for
the development of NPC in Chinese populations.
8
More than
95 per cent of adults in all ethnic groups across the world are
healthy carriers of EBV. In high NPC incidence regions, EBV
infection of the nasopharyngeal epithelium induces IgA
antibodies against VCA, suggesting that reactivation of EBV
replication at the mucosal surface precedes the development of
NPC. Consistent with this, approximately 2.5 per cent of
the general population are EBV/IgA/VCA antibody positive.
Of these, less than 3 per cent will develop NPC, while
.95 per cent of all NPC patients are EBV/IgA/VCA antibody
positive.
9–14
In addition to EBV infection, case control studies
have indicated a role for environmental factors, including food
preservatives (carcinogenic nitrosamines), salt-preserved ﬁsh and
phorbol esters in herbs and plants that are commonly consumed
among ethnic populations with the highest NPC rates.
15,16
Evidence for genetic modulation of NPC risk has accu-
mulated recently. Familial aggregation of NPC has been
observed in China and in other countries.
17–19
Familial
aggregation of NPC is uncommon in low-risk or non-
Chinese populations. The proportion of NPC with affected
ﬁrst-degree family history is .5 per cent in south China,
7.2 per cent in Hong Kong, 6.0 per cent in Yulin and 5.9
per cent in Guangzhou.
20
Descendants of south Chinese
immigrants to western countries show progressively lower risk,
but their NPC incidence remains higher than that of the
indigenous population,
21
suggesting both environmental and
genetic components to disease susceptibility. Several studies
have shown associations between HLA genes and NPC,
22–28
and the D6S1624 microsatellite within the HLA class I region
has been associated with NPC.
29
Studies comparing age of
NPC onset report conﬂicting results for familial versus
sporadic NPC. In a study comparing 200 probands with and
without NPC-affected ﬁrst-degree relatives from Singapore,
the age of onset was 48 and 49 years, respectively.
30
In another
Chinese study, the average age of onset was 35.5 years in 32
Guangdong families with 4–5 relatives with NPC compared
with 46.6 years for sporadic cases.
20
In a third study, however,
the age of onset decreased from 44.5 years to 40.4 as the
number of NPC-affected relatives increased from one to
four.
31
There is, therefore, some suggestion that age of onset
may be lower in families with one or more NPC-affected
ﬁrst-degree relatives.
A genome-wide linkage analysis of 20 NPC families from a
high incidence region in Guangdong identiﬁed a susceptibility
region on the short arm of chromosome 4.
32
Two chromo-
some 4p15.1-q12 markers, D4S405 and D4S3002, yielded
high logarithm of the odds (LOD) scores (.3.5) by both
parametric and multipoint non-parametric analysis in 70 per
cent of the NPC families studied. A subsequent study of
18 families from Hunan province genotyped a panel of
markers on the short arms of chromosomes 3, 9 and 4 that
included D4S405 and D4S3002 and failed to detect an
obvious susceptibility locus on 4p15.1-q12.
33
A region on
chromosome 3p21.31-21.2 containing a tumour suppressor
gene cluster, however, showed a modest association with NPC
incidence.
33
Here, we describe the design of a new case—control study
population recruited for the discovery of genetic factors that
are involved in the development of chronic EBV infection and
in the development of NPC. In a preliminary test to resolve
the discrepancy between the two family-based studies, we
performed a population-based case—control association
analysis of 34 microsatellite markers within 4p15.1-q12
(Figure 1) to determine if speciﬁc alleles within the region: 1)
were associated with a propensity to develop chronic EBV
replication, as evidenced by IgA antibodies against EBV viral
capsid antigen (EBV/IgA/VCA); or 2) were associated with
NPC susceptibility.
Materials and methods
Study design
Enrolment into the study occurred in two collection phases.
The Phase I pilot was powered to detect single gene associ-
ations and to determine feasibility for meeting recruitment
goals, accuracy of data collection and sample handling, and to
develop the infrastructure for a large international collabor-
ation. Cases and controls (n ¼ 984) were recruited in 2000
from Wuzhou City and Cangwu County, bordering the
Xijiang River in the Guangxi province of South East China.
An effort was made to enrol triads consisting of a proband, an
unaffected spouse and an adult child or parent. Family triads
were enrolled for haplotype inference and for quality control
assessment. Three clinically described disease categories were
collected: 1) incident or prevalent NPC biopsy-conﬁrmed
(NPC
þ
) cases (n ¼ 350) who were EBV/IgA/VCA antibody
positive (IgA
þ
); 2) IgA
þ
cases (n ¼ 288) who were deﬁned as
EBV/IgA/VCA antibody positive and NPC free at the time of
study enrolment (EBV/IgA/VCA titres were conﬁrmed by
serological testing at the time of study enrolment); 3) IgA
2
controls (n ¼ 346). For each case, his or her spouse was tested
for EBV/IgA/VCA antibodies, and the spouse and parent or
adult child were invited to enrol. The IgA
2
group consisted of
346 spouses who were IgA
2
at the time of study enrolment
(Table 1). A dominant model was selected for power calcu-
lations for two reasons: 1) if the true model is additive, there is
little difference in power using either an additive model or a
dominant model for power calculations (data not shown); 2) if,
however, the true model is dominant, a dominant model is the
most powerful. Assuming a dominant genetic model and at
least a 10 per cent allele frequency, this number of NPC, IgA
þ
,
and IgA
2
cases and controls provided .90 per cent power to
detect associations with an odds ratio (OR) $3, at the
p ¼ 0.01 level for a two-tailed test (Table 2).
Phase II enrolment was initiated in 2004 and after the
completion of Phase I collection. The Phase II design is a
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cross-sectional, case control study: family members were not
recruited. A questionnaire capturing environmental factors,
including occupational, dietary and tobacco exposures, was
administered to each study participant at enrolment (Table 3).
NPC cases were recruited from the Wuzhou Red Cross
Hospital in collaboration with the Cancer Institute of
Wuzhou, Wuzhou City and the Cangwu Institute for
Nasopharyngeal Carcinoma Control and Prevention, Cangwu
County. NPC cases, IgA
þ
subjects and IgA
2
participants were
recruited from cities and villages bordering the Xijiang River.
Power was determined for single gene and gene environment
interactions for participants in each group (Table 2). For
single-gene associations at a 10 per cent allele frequency,
power will range from 83 per cent to . 99 per cent and from
35 per cent to . 99 per cent to detect associations with
an odds ratio (OR) of 1.5–3.0 at p , 0.05 and p , 0.001,
respectively, for the dominant genetic model and a two-sided
signiﬁcance level. For gene-environment interactions, there is
power to detect gene-environment effects for genotype and
exposures with frequencies $ 0.1 for genotype and exposure,
if the main exposure effect and genotype have an OR $1 and
an interaction effect of OR $ 3.
34
Exclusion criteria for Phases I and II were ethnicity other
than Han Chinese, birth or residency for more than six
months outside of the NPC endemic region or failure to
provide informed consent. Internal review board approval was
obtained from all participating institutions and informed
consent was obtained from each study participant or their
guardian for subjects between 16 and 18 years of age.
Sample and data handling
A total of 10–20ml of blood was collected in acid citrate
dextrose (ACD) vacutainers for serology testing, direct DNA
extraction and for cryopreservation of peripheral blood
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Figure 1. Map of markers for the nasopharyngeal carcinoma susceptibility locus on chromosome 4.
28
Thirty-four short tandem repeat
markers distributed across an 18 megabase region were selected between D4S2950 to D4S2916, with intervals of 10–3,500 kilobases.
The positional relationship among markers and selected genes are indicated below the map. Asterisks indicate levels of statistical
signiﬁcance:
*
p , 0.05 and
* *
p , 0.01.
Table 1. Characteristics of the Phase I study groups.
NPC positive NPC negative
EBV/IgA/VCA positive EBV/IgA/VCA negative
No. study participants 350 288 346
Male/female (%male) 233/117 (67%) 142/146 (49%) 129/217 (59%)
Age* 48 ^ 10 (16–79) 44 ^ 9 (20–77) 47 ^ 10 (18–75)
IgA/VCA titre 1:10–1:640 1:5–1:80 ,1:5
IgA/EA titre 1:10–:160 (57.4%) 1:5–1:20 (5%) ,1:5
Abbreviations: EBV, Epstein–Barr virus; IgA, immunoglobulin A; NPC, nasopharyngeal carcinoma; VCA, viral capsid antigens.
*
Age at NPC diagnosis and at study enrolment for IgA serostatus.
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mononuclear cells (PBMCs). Blood samples were separated
into plasma and PBMCs. Serum was tested at the Wuzhou
Centre for EBV/IgA/VCA antibodies and antibodies to EBV
early antigen by immunoenzymatic assay. The PBMCs were
EBV-transformed to establish lymphoblastoid cell lines (LCLs)
as a renewable DNA source. In addition, 3 cc of whole blood
were preserved in DNA Tris, ethylene diamine tetraacetic acid
and sodium dodecyl sulphate extraction buffer as a back-up
DNA source. Questionnaires capturing demographic,
laboratory and social history were administered at enrolment.
Two individuals entered responses to the questionnaire and
laboratory results into a FileMaker Pro database independently
as a method of capturing data entry errors.
Genomic DNA extraction
DNA was extracted from whole blood or lymphoblastoid cell
lines using the QIAamp DNA blood maxi kit (Qiagen,
Valencia, CA, USA, catalog #51194). More than 80 per cent
Table 2. Phase I and phase II sample power.
Phase I Phase II All
Case/control Power Case/control Power Case/control Power
NPC+ vs IgA+ 350/288 1024/1009 1374/1297
OR 0.75 1.5 17% 64% 79%
0.50 2.0 62% .99% .99%
0.33 3.0 98% .99% .99%
IgA+ vs IgA2 288/346 1009/1022 1297/1368
OR 0.75 1.5 18% 64% 79%
0.50 2.0 64% 99% .99%
0.33 3.0 99% .99% .99%
NPC+/IgA+ vs IgA2 638/346 2033/1022 2671/1368
OR 0.75 1.5 25% 77% 90%
0.50 2.0 78% .99% .99%
0.33 3.0 .99% .99% .99%
Note. Allele frequency ¼ 10 per cent; Type 1 error ¼ 1 per cent.
Power calculated for a 10% allele frequency, dominant genetic model and a p value of #0.01 for given case and control numbers using a two-tailed test. For example, with the
Phase I cases/controls available, we would discover a genetic association of strength OR ¼ 1.5, only 14% of the time, but a stronger gene (OR ¼ 3.0) would be detected 96%
of the time with available patient numbers.
Abbreviations: IgA, immunoglobulin A; NPC, nasopharyngeal carcinoma.
Table 3. Phase II study design and non-genetic covariates.
Exposure EBV/IgA/VCA status
NPC/IgA+ IgA
+
IgA
2
No. enrolled
1
1024 1009 1022
Male:female (% male) 735/289 (72%) 555/454 (55%) 684/338 (67%)
Consume dried meat
2
292 (28.5%) 172 (17.0%) 283 (27.7%)
Wood cooking ﬁres
2
995 (97.2%) 960 (95.1%) 914 (89.4%)
Occupational exposure to solvents
2
78 (07.6%) 31 (03.1%) 87 (08.5%)
Smoking .10 years 531 (51.9%) 408 (40.4%) 372 (36.4%)
Abbreviations: EBV, Epstein–Barr virus; IgA, immunoglobulin A; NPC, nasopharyngeal carcinoma; VCA, viral capsid antigens.
1
Greater than 99 per cent of IgA
þ
and IgA
2
participants and 100 per cent of the NPC cases were born in Guangdong or Guangzhou provinces.
2
Participants reporting any level exposure.
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of the genotypes were determined from DNA directly
extracted from whole blood.
Microsatellite genotyping
Microsatellite loci (n ¼ 34) containing 319 alleles were selected
between D4S2950 and D4S2916 (18 megabases [Mb]) on
chromosome 4 (Figure 1). The markers consist of 22 dinucleo-
tide repeats, two trinucleotide repeats and ten tetranucleotide
repeats. The genetic and physical distances betweenmarker pairs
are as follows: mean ¼ 0.51 centimorgans (cM), 562 kilobases
(kb); median ¼ 0.34 cM, 230 kb; and range ¼ 0.00–2.79 cM,
11–4,185 kb. The primer sequences were obtained from the
Universityof SantaCruzGenomeBioinformatics database.
35
All
of the forward primers were 5
0
-tailed with theM13 sequence 5
0
-
CACGACGTTGTAAAACGAC-3
0
. The M13-forward pri-
merswere used in combinationwith anM13 primer that had the
same sequence but was labelled at its 5
0
end with a ﬂuorescent
reagent from Applied Biosystems (ABI) Foster City, CA, USA
such as 6-FAM,VICorNED.The latter primer is the sole source
of label and can be used with any M13-forward primer to gen-
erate a labelled ampliﬁed allele.
36
The polymerase chain reaction
(PCR) ampliﬁcations of individual microsatellite loci were
performed in 10ml volumes containing 10mM Tris–HCl (pH
8.3), 50mMKCl, 2.0mMMgCl
2
, 0.2mMof each dinucleotide
triphosphate, 1mM labelled M13 primer and reverse primer,
0.07mM M13-tailed primer (15:1 molar ratio of labelled M13
primer versus a M13-tailed forward primer), 25 ng genomic
DNA, 0.5 U TaqGold DNA polymerase (Applied Biosystems,
Foster City, CA, USA). PCR ampliﬁcation was performed in a
PE Applied BiosystemsModel 9700 using 384 high-throughput
format plates. The PCR conditionswere amodiﬁed touchdown
PCR procedure: 958C, 10minutes; two cycles of 958C,
15 seconds; annealing temperature, 30 seconds; 728C,
45 seconds, at annealing temperatures of 608C, 588C, 568C,
548C, 528C; 30 cycles at an annealing temperature of 508C;
728C, 30minutes. Six PCR products were pooled together for
multiplex loading according to the label colour and marker size.
Samples were diluted appropriately, pooled and then 3ml of
sample was mixed with 9ml of formamide containing Liz 350
size standard (ABI). Samples were electrophoresed in a 22 cm
capillary array using POP5 polymer and 3700 running buffer
(ABI) on anABIModel 3100AutomatedDNASequencer using
data collection software version 1.0.1 and Genescan Analysis
software version 3.7. Genotyping was performed using Geno-
typer Version 2.5 and allele sizes were binned using Allelogram
(Carl Manaster, available at http://s92417348.onlinehome.us/
software/allelogram/index.html). For quality control between
plates, DNAs from 22 per cent of subjects were duplicated across
plates. Mendelian errors were tested within the triad families
using the PedChek program.
37
Genetic association analyses
Allele frequencies were computed and compared between
cases and controls using Pearson’s x
2
test or Fisher’s exact test.
ORs, 95 per cent conﬁdence intervals (CIs) and p values
were computed for dominant and recessive genetic models
adjusted for age and sex. Logistic regression adjusted for age
and sex was used to compute ORs using SAS PROC
LOGISTIC software (SAS Institute, Cary, NC, USA). ORs
were computed for a dominant model, comparing the com-
bined homozygous and heterozygous genotypes against all
other genotypes. When the allele frequency of the minor allele
was $5 per cent, ORs were calculated for the recessive
model, comparing the homozygous genotype against all other
genotypes. Conformance to Hardy–Weinberg equilibrium
expectations was calculated for all loci. Tests for D’ as a
measure of linkage disequilibrium (LD) were conducted for
allele pairs using SAS Genetics software (SAS Institute, Cary,
NC, USA).
Results
The Phase I pilot study enrolled participants from the Cancer
Institute in Wuzhou City and the Cangwu Institute for
Nasopharyngeal Carcinoma Control and Prevention, Cangwu
County in Guangxi province in the autumn of 2000. For
NPC cases, 71.3 per cent of spouses and 81 per cent of adult
children were enrolled. For cases with EBV/IgA/VCA titres
consistent with chronic EBV infection, 72.4 per cent of
spouses and 67.4 per cent of adult children or parents were
enrolled. Complete triad sets were available for 366 NPC
probands. As predicted for this highly endemic NPC region,
71.8 per cent of the NPC cases were male. PBMCs cryopre-
served on-site were transported to the Laboratory of Genomic
Diversity-National Cancer Insitute (LGD-NCI) for EBV
immortalisation: 83 per cent of 633 transformation attempts
resulted in LCLs.
Sample and genotyping errors were estimated by including
10 per cent duplicate sampling with one sample derived
from DNA isolated directly from peripheral blood and the
second from DNA isolated from LCLs. Less than 0.5 per cent
mismatches within duplicate samples were observed, all of
which were resolved using family trios, indicating that tubes
collected from a single individual were appropriately labelled
(data not shown) and that error was not introduced during cell
line development or sample handling. A second test for
Mendelian errors using PedChek was performed using the
chromosome 4 microsatellite data (described below). Two
unresolved Mendelian errors were observed within the 366
family triads. Near-complete genotyping and complete clinical
data were available for 350 NPC cases, 288 IgA seropositives
and 346 IgA seronegatives (Table 1).
Phase II enrolment occurred between November 2004 and
July 2005 in Guangxi province. Subjects were enrolled if
at least one parent was from the Guangxi or Guangdong
provinces. NPC cases were identiﬁed as seroincident or
seroprevalent cases presenting at Red Cross hospitals and
IgA
þ
and IgA
2
controls were identiﬁed from ﬁeld stations in
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cities and villages bordering the Xijiang River drainage.
Table 3 presents summary data of environmental exposures
for the Phase II NPC
þ
, IgA
þ
and IgA
2
groups and the
numbers of participants enrolled.
We have addressed the questions of whether a locus within
the chromosome 4p15.1-q12 region leads to the development
of NPC or the development of EBV/IgA/VCA in response to
EBV replication using the Phase I cases and controls. Micro-
satellite loci (n ¼ 34) were distributed over an 18Mb region on
chromosome 4p15.1-q12, with intervals of 10–3,500 kb and an
average distance of 530 kb. Four Phase I genetic association
comparisons were made: 1) NPC cases versus EBV/IgA/VCA
seropositive controls (Table 4); 2) EBV/IgA/VCA seropositive
cases without NPC versus EBV/IgA/VCA seronegative con-
trols (Table 5); 3) NPC cases plus EBV/IgA/VCA seropositive
cases versus EBV/IgA/VCA seronegative controls (Table 6);
and 4) NPC cases versus EBV/IgA/VCA seronegative controls
(data not shown). No distortions in Hardy-Weinberg equili-
brium were observed. Alleles with at least one signiﬁcant result
( p , 0.05) for either the dominant or recessive genetic models
are reported in Tables 4–6. The results are presented without
correction for multiple comparisons because the interrogated
4p15.1-q12 region was previously implicated as a susceptibility
locus in a family-based study and we were speciﬁcally testing
the prior hypothesis that markers within the region would also
be associated with NPC in a population-based study.
32
It should
be noted that associations with p .0.0015 would not remain
signiﬁcant after correction for multiple comparisons consider-
ing the 34 independent loci.
Linkage disequilibrium among the 34 loci
The spacing of markers varied from 10–3,500 kb, with denser
coverage ﬂanking the microsatellite markers with the highest
LOD scores from the family study (Figure 1). We calculated
two-point D’ as a measure of LD between all alleles at
neighbouring short tandem repeat loci; however, a D’ value of
1 (complete LD) was observed for only 60 two-point allele
combinations. Using HapMap single nucleotide polymorph-
ism (SNP) data (http://www.hapmap.org), we examined
whether the microsatellites were included in reasonably strong
LD blocks. The r
2
between any given marker pairs were
set at a 0.8 cut-off threshold to determine the LD blocks.
Only 11 of the 34 microsatellite markers occurred within an
LD block: D4S396 and D4S401 occurred within the same
17 kb block. Of the two NPC-linked markers,
32
D4S405
was not within a block and D4S3002 occurred within an
8 kb block. The mean size of the blocks was 17.9 kb
(range 8–50 kb).
Genetic association with NPC
Table 4 presents the locus name, location, allele length, allele
frequencies, ORs, p values and 95 per cent CIs for 350
NPC cases and 288 EBV/IgA/VCA seropositive controls
(93.0–99.7 per cent of NPC cases and 91.0–97.6 per cent
of IgA
þ
subjects were genotyped successfully). The genotype
frequencies among NPC cases were signiﬁcantly higher than
those among control subjects for ﬁve alleles (OR 1.51–5.36;
p ¼ 0.01–0.03): for the recessive model, D4S3040-215 and
D4S1547-251; and for the dominant model, D4S3040-213,
D4S2974-137 and D4S2916-204. The genotype
frequencies among NPC cases was statistically lower than
among control subjects for four alleles (OR 0.3–0.71;
p ¼ 0.02–0.045): for the recessive model, D4S2950-141 and
D4S2974-135; and for the dominant model, D4S3357-271
and D4S2381-277.
Genetic association with persistent IgA
1
status
To test the hypothesis that genetic factors may inﬂuence EBV/
IgA/VCA formation in response to EBV infection, we com-
pared genotype frequencies between 288 IgA
þ
cases and 346
IgA
2
controls (Table 1). Table 5 provides the allele frequen-
cies, p values, ORs and 95 per cent CIs in cases and controls
for signiﬁcant results. Eleven alleles were signiﬁcantly associ-
ated with IgA
þ
persistence: ﬁve risk alleles (OR 1.51–2.38;
p ¼ 0.004–0.040) and six protective alleles (OR 0.33–0.70;
p ¼ 0.002–0.050).
Because all NPC cases in our study were IgA
þ
, we then
pooled NPC and IgA
þ
cases together to increase power, with
the hypothesis being that the alleles associated with IgA
þ
serostatus would be shared among NPC
þ
IgA
þ
and
NPC
2
IgA
þ
individuals. Signiﬁcant associations are presented
in Table 6: four alleles were associated with risk for IgA
þ
(OR
1.5–1.63; p ¼ 0.001–0.030) and seven were protective (OR
0.46–0.76; p ¼ 0.001–0.050). Based on the two comparisons
(Tables 5 and 6), ten alleles associated with IgA were shared in
both comparisons. Five were highly signiﬁcant ( p ,0.01)
associations with IgA
þ
serostatus. Alleles D4S190-170
( p ¼ 0.005; OR 1.5, 95% CI 1.13–2.0), D4S3241-136
( p ¼ 0.004; OR 1.91, 95% CI 1.2-3.0) and D4S3347-213
( p ¼ 0.001; OR 1.58, 95% CI 1.2-2.1) signiﬁcantly increased
the risk of developing EBV/IgA/VCA. Alleles D4S174-202
( p ¼ 0.001; OR 0.46, 95% CI 0.3-0.7) and D4S2950-137
( p ¼ 0.0036; OR 0.56, 95 per cent CI 0.38-0.83) signiﬁcantly
decreased the risk of EBV/IgA/VCA. Within a single locus
(D4S3357), one allele increased susceptibility (D4S3357-271)
and the other allele was protective (D4S3357-275).
Discussion
We have described the design and recruitment efforts for a
genetic association study to investigate the role of host genetic
factors in the development of chronic EBV infection
leading to NPC in subjects born and living in a region with
one of the world’s highest incidence rates of NPC. This study
was conducted in two phases. Phase I was a pilot study to
explore the feasibility of conducting a cross-sectional study
Guo et al.ReviewPRIMARY ESEARCH
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in China (Table 1). The pilot provided strong support for
expanding the study in several important ways: export permits
for genetic material were obtained, sample handling was
excellent—with few detectable errors— and recruitment
goals were attainable. Upon the successful completion of Phase
I, we increased the catchment area for IgA
þ
cases to cities
and villages along the Xijiang River and tributaries, expanded
the study to include more subjects and added a detailed
questionnaire to capture environmental exposures that may
interact with host genes in the development of NPC (Table 2).
Complementing previous studies, we also attempted to deter-
mine if Phase II of the study was powered for the detection
of both gene–gene and gene–environment interactions.
To revisit the recent linkage analysis in NPC families
implicating a susceptibility locus linked to chromosome
4p15.1-q12, we selected 34 microsatellite loci spanning the
18Mb region at intervals of 10–3,500 kb. Unlike in previous
studies, we ﬁrst also attempted to determine if the chromo-
some 4 region was associated with EBV/IgA/VCA antibody
formation and, secondly, if the chromosome 4 region was
associated with NPC incidence in the setting of EBV repli-
cation as indicated by EBV/IgA/VCA. We identiﬁed several
loci that showed signiﬁcant associations with either EBV/IgA/
VCA or NPC status. The associations tended to be marginally
signiﬁcant for NPC (Table 4), with somewhat stronger
associations observed for EBV/IgA/VCA (IgA
þ
)
(Tables 5 and 6).
Few NPC families have been identiﬁed outside of NPC
endemic areas. More than 90 per cent of all NPC cases do not
show familial aggregation or family history, implying either
environmental causes or geographical family clustering. Two
family-based NPC linkage studies implicated different
chromosomes as harbouring an NPC susceptibility locus.
32,33
Although the studies differed in strategy, both used multiple
families with two or more NPC cases from two separate high
NPC incident provinces in China and included similar num-
bers of families and affected cases. Although it is possible
that environmental exposures may differ between the two
provinces, it is unlikely that different environmental factors
account for the lack of concordance between the studies.
More likely, multiple genes predispose to chronic EBV repli-
cation and the development of NPC, each of which may
contribute only a small part of the total genetic inﬂuence.
Family-based linkage studies are ideal for identifying single
genes with large effects, but are relatively insensitive for
localising genetic factors with small effects. By contrast, case-
control association studies are ideal for identifying genetic
factors with small or moderate effects once a candidate gene or
region has been identiﬁed.
38
We cannot exclude the possibility that there may be causal
alleles in the chromosome 4 region that may be associated
with chronic EBV replication or a predisposition to develop
NPC. Marker associations within this region (Tables 4–6) may
be tracking a susceptible locus through LD. Because included
alleles predominantly occurred at very low frequencies and
haplotype inferences were unreliable, we could not reliably
assess associations with either EBV persistence or NPC (data
not shown). A denser placement of polymorphic markers is
required to survey the genetic variation content of the region
more thoroughly.
Although this study did not ﬁnd associations with robust p
values for NPC, making conclusions tentative, a number of loci
did show moderate to strong risk, suggesting that this region
warrants further attention, particularly for chronic EBV repli-
cation. For one of the microsatelite loci D4s3347 (Tables 5
and 6), two alleles were associated with EBV/IgA/VCA,
suggesting that these alleles may be tracking a potential causative
allele (see Figure 1). Of potential interest is the association of
two microsatellites with IgA incidence: D4S3347, which
shows three signiﬁcant associations with p , 0.01 and one
with p , 0.05 for two alleles (213 and 217), and the tightly
linked (,20 kb) D4S1577 locus, which also shows four sig-
niﬁcant associations ( p , 0.05) (Tables 5 and 6, Figure 1).
Microsatellite D4S190 occurs within the oncogene ARHH.
D4S190 was associated with risk for EBV/IgA/VCA seroposi-
tive status but not with NPC. ARHH, a member of the ras
homolog gene family, encodes a small GTP-binding protein
belonging to the RAS superfamily and is transcribed by only
haemopoietic cells. ARHH non-coding variants that may affect
expression are observed in 46 per cent of diffuse large-cell
lymphomas.
39
It is possible that one or more variant alleles
of ARHH in LD with associated D4S190-170 may modify
EBV replication.
Given the similar geographical distribution of familial and
non-familial NPC, it is likely that both forms share similar
aetiological risk factors, particularly environmental and viral
factors; however, it is likely that the genetic factors under-
pinning familial, early-onset and non-familial NPC suscepti-
bility may also overlap. It is also possible that different genes
contribute to familial NPC cases, analogous to the situation in
breast cancer, where BRCA1 and BRCA2 account for only
a small proportion of non-familial breast cancer cases.
40,41
The best approach to identifying NPC susceptibility factors
may be the organisation of well-designed and highly powered
case–control studies for whole-genome and targeted candidate
gene association investigations, as we describe here.
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